Debates & Insights

News

Press Releases

Newsletters and Deep Dive
digital magazine

Views & Analysis

R&D
pharmaphorum podcast episode 98

Turning drug development on its head

Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho

Deep Dive

R&D
Around the world in pharma events

Around the world in pharma events

Stay up to date with key industry meetings and conferences in 2023 Americas FT US Pharma & Biotech Summit 16-17-May New York, US

R&D

What’s next for oncology research?

Eliminating cancer as a cause of death is a highly ambitious goal, but oncology researchers are showing no signs of giving up the fight in 2023.

Webinars

Podcasts

R&D
pharmaphorum podcast episode 98

Turning drug development on its head

Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho

R&D
pharmaphorum podcast episode 93

Alzheimer’s drugs: An overview and update

When we covered JP Morgan in January, over and over we heard that neurodegenerative diseases, especially Alzheimer’s, were going to be one of the most exciting spaces in pharma this year.

Video

R&D
Health Innovators Jennifer Schranz

Health Innovators – Jennifer Schranz

In the rare and ultra-rare disease space, the paucity of both data and patients makes everything about research and development more complicated.

R&D
Health Innovators Cytokinetics

Health Innovators – Fady Malik and Steve Heitner

In this instalment of Health Innovators, EiC Jonah Comstock sits down virtually with Fady Malik, EVP of research and development at Cytokinetics and Steve Heitner, the company’s VP of clinical rese

R&D
Reuters Pharma USA – Lung-I Cheng

Reuters Pharma USA – Lung-I Cheng

Cell and gene therapies continue to be hot topics in the pharma world this year, and some companies are responding to the new treatment modalities with new business units.

Event

R&D
FT LiveUS Pharma and Biotech Summit 2023

FT Live US Pharma and Biotech Summit 2023

At the FT’s US Pharma and Biotech Summit in New York City, 16th and 17th May, leaders from across the pharma landscape will gather to discuss some of the hottest topics in US pharma, includ

Partner Content

R&D
mRNA Assay Development Summit 2023
Partner Content

mRNA Assay Development Summit 2023

The mRNA Assay Development Summit is the first and only meeting to address the specific technical challenges of analytical, bioanalytical and potency assay development.